Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Lateral flow assays (LFAs) are point-of-care devices that are known for their ...

In his laboratory at the University of Poitiers in France, Abderrazak El Albani contemplates the rock glittering in his hands. To the untrained eye, the specimen resembles a piece of golden tortellini ...

ADCs integrate monoclonal antibodies with cytotoxic payloads, offering new treatment options for NSCLC, including biomarker-selected and biomarker-agnostic patients. ADCs are composed of an antibody, ...

Key Takeaway: Complex has launched its new iOS mobile app, combining the brand's trusted editorial content with an exclusive shopping experience featuring drops from 100+ streetwear and lifestyle ...

Singapore-based AI startup Sapient Intelligence has developed a new AI architecture that can match, and in some cases vastly outperform, large language models (LLMs) on complex reasoning tasks, all ...

Adagene Inc. has announced a partnership with ConjugateBio Inc. to provide a proprietary antibody for the development of innovative bispecific antibody-drug conjugates (ADCs). Adagene's CEO ...

Antibody-Drug Conjugates (ADCs) represent an emerging cancer therapeutic strategy and are becoming increasingly significant in the field of public health. With the evolution of precision oncology, the ...

NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the ...

In January 2020, just eight months into her tenure as CEO of Best Buy, Corie Barry learned about a novel coronavirus spreading in China. By early March, Barry was getting reports that the virus was ...

Antibody-drug conjugates (ADCs) are innovative treatments targeting specific cancer cell receptors, delivering cytotoxic agents directly to tumors, minimizing systemic exposure. ADCs have shown ...